Managing patients ahead of the Levemir discontinuation
Written by AlisonFreemantle on Wednesday 7th October 2026
Are you still dispensing any Levemir?
Levemir products are being discontinued in December 2026. Patients need to be switched to suitable alternatives as soon as possible and in line with the guidance below.
What has Happened
Novo Nordisk is discontinuing Levemir (insulin detemir) FlexPen 100units/ml solution for injection 3ml pre-filled pens and Levemir (insulin detemir) Penfill 100units/ml solution for injection 3ml cartridges.
Levemir is licensed in the treatment of Type 1 and Type 2 diabetes in adults, adolescents and children aged 1 year and above.
Medicines Supply Notifications have been issued outlining important guidance for clinicians.
Many patients still remain on Levemir products and require switching.
What Pharmacies need to do
- Highlight any patients still being prescribed Levemir.
- When patient collects their prescription, encourage them to speak to their prescriber as soon as possible and not to leave it until December.
Full information about the discontinuation and the actions healthcare professionals need to take can be found in the ABCD/PCDO guidance, which you can access via the QR code.

First published in July 2026.